Free Trial

Itron, Inc. $ITRI Shares Purchased by Intech Investment Management LLC

Itron logo with Computer and Technology background

Key Points

  • Intech Investment Management LLC increased its holdings in Itron, Inc. by 17.7% in the first quarter, now owning 48,699 shares valued at approximately $5.1 million.
  • Several institutional investors, including Janney Montgomery Scott LLC and Evergreen Capital Management LLC, also raised their stakes in Itron during the same period, indicating strong institutional interest.
  • Itron recently reported $1.62 EPS for the last quarter, surpassing analysts' expectations, while also providing FY 2025 EPS guidance between 6.000-6.200.
  • Five stocks to consider instead of Itron.

Intech Investment Management LLC raised its holdings in shares of Itron, Inc. (NASDAQ:ITRI - Free Report) by 17.7% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 48,699 shares of the scientific and technical instruments company's stock after buying an additional 7,336 shares during the quarter. Intech Investment Management LLC owned about 0.11% of Itron worth $5,102,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Invesco Ltd. grew its holdings in shares of Itron by 2.7% in the first quarter. Invesco Ltd. now owns 2,310,769 shares of the scientific and technical instruments company's stock valued at $242,076,000 after purchasing an additional 59,962 shares during the period. Amundi grew its holdings in shares of Itron by 18.4% in the first quarter. Amundi now owns 929,407 shares of the scientific and technical instruments company's stock valued at $97,313,000 after purchasing an additional 144,361 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Itron by 129.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 732,274 shares of the scientific and technical instruments company's stock valued at $76,713,000 after purchasing an additional 413,487 shares during the period. Nuveen Asset Management LLC grew its holdings in shares of Itron by 21.5% in the fourth quarter. Nuveen Asset Management LLC now owns 560,478 shares of the scientific and technical instruments company's stock valued at $60,857,000 after purchasing an additional 99,142 shares during the period. Finally, Wellington Management Group LLP grew its holdings in shares of Itron by 15.2% in the first quarter. Wellington Management Group LLP now owns 384,152 shares of the scientific and technical instruments company's stock valued at $40,244,000 after purchasing an additional 50,789 shares during the period. Hedge funds and other institutional investors own 96.19% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the stock. Guggenheim reissued a "buy" rating and issued a $155.00 price objective (up previously from $133.00) on shares of Itron in a report on Monday, July 14th. Stephens set a $130.00 price objective on shares of Itron in a report on Monday, August 4th. Johnson Rice lowered shares of Itron from a "buy" rating to an "accumulate" rating in a report on Friday, August 1st. TD Cowen upped their target price on shares of Itron from $139.00 to $145.00 and gave the company a "buy" rating in a research report on Friday, June 20th. Finally, Roth Capital upped their target price on shares of Itron from $130.00 to $150.00 and gave the company a "buy" rating in a research report on Tuesday, July 22nd. Ten research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $136.55.

Read Our Latest Stock Analysis on ITRI

Insider Buying and Selling at Itron

In other news, SVP John F. Marcolini sold 565 shares of the stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $125.31, for a total transaction of $70,800.15. Following the sale, the senior vice president owned 14,396 shares of the company's stock, valued at approximately $1,803,962.76. This represents a 3.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Christopher E. Ware sold 351 shares of the firm's stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $125.31, for a total transaction of $43,983.81. Following the completion of the sale, the senior vice president directly owned 19,117 shares in the company, valued at approximately $2,395,551.27. This trade represents a 1.80% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 3,037 shares of company stock valued at $380,566. Corporate insiders own 1.45% of the company's stock.

Itron Stock Up 2.6%

Shares of ITRI traded up $3.02 during mid-day trading on Thursday, hitting $120.93. 163,675 shares of the company's stock were exchanged, compared to its average volume of 591,729. The company has a market cap of $5.53 billion, a price-to-earnings ratio of 20.67, a P/E/G ratio of 0.64 and a beta of 1.46. Itron, Inc. has a fifty-two week low of $90.11 and a fifty-two week high of $140.04. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.75 and a current ratio of 2.04. The stock's 50-day moving average is $126.94 and its 200-day moving average is $117.63.

Itron (NASDAQ:ITRI - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.33 by $0.29. The business had revenue of $606.76 million for the quarter, compared to analysts' expectations of $610.36 million. Itron had a net margin of 11.05% and a return on equity of 19.69%. The business's quarterly revenue was down .4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.21 earnings per share. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. On average, sell-side analysts anticipate that Itron, Inc. will post 5.33 earnings per share for the current fiscal year.

Itron Company Profile

(Free Report)

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.

Featured Stories

Institutional Ownership by Quarter for Itron (NASDAQ:ITRI)

Should You Invest $1,000 in Itron Right Now?

Before you consider Itron, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.

While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.